These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 10622673

  • 1. The interrelations between psychosis, behavioral disturbance, and depression in Alzheimer disease.
    Devanand DP.
    Alzheimer Dis Assoc Disord; 1999 Nov; 13 Suppl 2():S3-8. PubMed ID: 10622673
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Anosognosia in Alzheimer's disease: association with patient characteristics, psychiatric symptoms and cognitive deficits.
    Kashiwa Y, Kitabayashi Y, Narumoto J, Nakamura K, Ueda H, Fukui K.
    Psychiatry Clin Neurosci; 2005 Dec; 59(6):697-704. PubMed ID: 16401246
    [Abstract] [Full Text] [Related]

  • 5. A longitudinal evaluation of behavioural and psychological symptoms of probable Alzheimer's disease.
    Eustace A, Coen R, Walsh C, Cunningham CJ, Walsh JB, Coakley D, Lawlor BA.
    Int J Geriatr Psychiatry; 2002 Oct; 17(10):968-73. PubMed ID: 12325059
    [Abstract] [Full Text] [Related]

  • 6. A retrospective study of the behavioural and psychological symptoms of mid and late phase Alzheimer's disease.
    Hart DJ, Craig D, Compton SA, Critchlow S, Kerrigan BM, McIlroy SP, Passmore AP.
    Int J Geriatr Psychiatry; 2003 Nov; 18(11):1037-42. PubMed ID: 14618556
    [Abstract] [Full Text] [Related]

  • 7. [Validation of the Short Cognitive Battery (B2C). Value in screening for Alzheimer's disease and depressive disorders in psychiatric practice].
    Robert PH, Schuck S, Dubois B, Lépine JP, Gallarda T, Olié JP, Goni S, Troy S.
    Encephale; 2003 Nov; 29(3 Pt 1):266-72. PubMed ID: 12876552
    [Abstract] [Full Text] [Related]

  • 8. Cholinergic-serotonergic imbalance contributes to cognitive and behavioral symptoms in Alzheimer's disease.
    Garcia-Alloza M, Gil-Bea FJ, Diez-Ariza M, Chen CP, Francis PT, Lasheras B, Ramirez MJ.
    Neuropsychologia; 2005 Nov; 43(3):442-9. PubMed ID: 15707619
    [Abstract] [Full Text] [Related]

  • 9. [Psychotic symptoms and Alzheimer's disease].
    Alberca R, Gil-Néciga E, Salas D, Pérez JA, Lozano P.
    Neurologia; 2000 Jan; 15(1):8-14. PubMed ID: 10730061
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta-analysis of 4 placebo-controlled clinical trials.
    Katz I, de Deyn PP, Mintzer J, Greenspan A, Zhu Y, Brodaty H.
    Int J Geriatr Psychiatry; 2007 May; 22(5):475-84. PubMed ID: 17471598
    [Abstract] [Full Text] [Related]

  • 14. Quantitative electroencephalographic correlates of psychosis in Alzheimer disease.
    Edwards-Lee T, Cook I, Fairbanks L, Leuchter A, Cummings JL.
    Neuropsychiatry Neuropsychol Behav Neurol; 2000 Jul; 13(3):163-70. PubMed ID: 10910086
    [Abstract] [Full Text] [Related]

  • 15. Grouping and trajectories of neuropsychiatric symptoms in patients with Alzheimer's disease. Part II: two-year patient trajectories.
    Garre-Olmo J, López-Pousa S, Vilalta-Franch J, de Gracia Blanco M, Vilarrasa AB.
    J Alzheimers Dis; 2010 Jul; 22(4):1169-80. PubMed ID: 20930287
    [Abstract] [Full Text] [Related]

  • 16. Behavioral and psychological symptoms assessed with the BEHAVE-AD-FW are differentially associated with cognitive dysfunction in Alzheimer's disease.
    Ito T, Meguro K, Akanuma K, Meguro M, Lee E, Kasuya M, Ishii H, Mori E.
    J Clin Neurosci; 2007 Sep; 14(9):850-5. PubMed ID: 17587584
    [Abstract] [Full Text] [Related]

  • 17. Cognitive and behavioral features discriminate between Alzheimer's and Parkinson's disease.
    Cahn-Weiner DA, Grace J, Ott BR, Fernandez HH, Friedman JH.
    Neuropsychiatry Neuropsychol Behav Neurol; 2002 Jun; 15(2):79-87. PubMed ID: 12050470
    [Abstract] [Full Text] [Related]

  • 18. [Presentation and stability of cognitive and noncognitive symptom patterns in patients with Alzheimer's disease. Disease course over a two-year period under constant treatment conditions with rivastigmine].
    Wobrock T, Retz-Junginger P, Retz W, Supprian T, Rösler M.
    Fortschr Neurol Psychiatr; 2003 Apr; 71(4):199-204. PubMed ID: 12677553
    [Abstract] [Full Text] [Related]

  • 19. Cognition and behaviour are independent and heterogeneous dimensions in Alzheimer's disease.
    Spalletta G, Baldinetti F, Buccione I, Fadda L, Perri R, Scalmana S, Serra L, Caltagirone C.
    J Neurol; 2004 Jun; 251(6):688-95. PubMed ID: 15311344
    [Abstract] [Full Text] [Related]

  • 20. Disease progression in vascular cognitive impairment: cognitive, functional and behavioural outcomes in the Consortium to Investigate Vascular Impairment of Cognition (CIVIC) cohort study.
    Rockwood K, Moorhouse PK, Song X, MacKnight C, Gauthier S, Kertesz A, Montgomery P, Black S, Hogan DB, Guzman A, Bouchard R, Feldman H, Consortium to Investigate Vascular Impairment of Cognition (CIVIC) Cohort.
    J Neurol Sci; 2007 Jan 31; 252(2):106-12. PubMed ID: 17189642
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.